Introduction to Infectious Disease
Join us for an engaging online webinar that explores the fundamentals of infectious diseases—how they spread, how they’re prevented, and why they remain a critical global health concern. This session is perfect for students, healthcare professionals, and anyone interested in public health.
Market Insights in Infectious Disease
The global infectious disease therapeutics market is projected to grow significantly, valued at USD 123.91 billion in 2024 and expected to reach USD 179.91 billion by 2034, with a CAGR of 3.8%. Key drivers include rising prevalence of diseases like HIV, tuberculosis, and malaria, fueled by global travel, urbanization, and climate change. The HIV segment holds a significant share (29.12% in 2023), driven by 40 million cases globally. Innovations in diagnostics, antivirals, and vaccines, alongside antimicrobial resistance, propel market growth. North America dominates with 40% market share due to advanced healthcare infrastructure, while Asia-Pacific is the fastest-growing region due to rising health awareness and medical technology advancements. Challenges include high treatment costs, generic erosion, and regulatory hurdles. Strategic collaborations, mergers, and R&D investments by key players like Pfizer, Merck, and Gilead Sciences enhance treatment efficacy and market expansion, addressing global health threats effectively.